| Date | Time | Source | Headline | Symbol | Company |
| 15/04/2019 | 21:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 12/04/2019 | 18:01 | PR Newswire (US) | Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory a... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 10/04/2019 | 21:45 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 10/04/2019 | 21:35 | GlobeNewswire Inc. | Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019 | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 10/04/2019 | 21:19 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/04/2019 | 21:07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/04/2019 | 21:07 | GlobeNewswire Inc. | Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 02/04/2019 | 21:20 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 27/03/2019 | 20:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 27/03/2019 | 10:00 | GlobeNewswire Inc. | Vital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AG | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 25/03/2019 | 20:07 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 25/03/2019 | 09:00 | GlobeNewswire Inc. | Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Prop... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 22/03/2019 | 20:09 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 19/03/2019 | 21:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 14/03/2019 | 20:04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 13/03/2019 | 20:01 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/03/2019 | 22:17 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/03/2019 | 21:23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/03/2019 | 21:10 | GlobeNewswire Inc. | Vital Therapies Announces 2018 Financial Results | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 28/02/2019 | 21:21 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 26/02/2019 | 21:18 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 19/02/2019 | 22:05 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 15/02/2019 | 11:33 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 14/02/2019 | 14:04 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 06/02/2019 | 21:37 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 04/02/2019 | 23:01 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 01/02/2019 | 20:39 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 24/01/2019 | 22:07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 14/01/2019 | 21:53 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 07/01/2019 | 21:43 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |